FULLFORM ROTACAPS is indicated in the regular treatment of asthma, where use of a combination (long acting beta2-agonist and inhaled corticosteroid) has been found to be appropriate.
FULLFORM ROTACAPS are for inhalation use, only through the Cipla Rotahaler/Revolizer.
Contraindications
FULLFORM ROTACAPS is contraindicated in patients with a history of hypersensitivity to any of the components of the drug product.
Reviews
There are no reviews yet.